Euthyroid 50 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Hypothyroidism. Secondary and off-label uses of Euthyroid 50 Tablet have also been mentioned below.
The correct dosage of Euthyroid 50 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Euthyroid 50 Tablet as well, which are listed below. Such side effects of Euthyroid 50 Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Euthyroid 50 Tablet is Safe for pregnant women and Mild for women who are breastfeeding. Warnings related to Euthyroid 50 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Euthyroid 50 Tablet is contraindicated in people with pre-existing medical conditions like Heart Disease, Hypopituitarism as it can result in adverse effects. Other conditions have been mentioned below in the Euthyroid 50 Tablet contraindications section.
Drug reaction of Euthyroid 50 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Euthyroid 50 Tablet is safe while driving, and is addiction.
Euthyroid 50 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Based on research, the following side effects have been observed when Euthyroid 50 Tablet is used -
Is the use of Euthyroid 50 Tablet safe for pregnant women?
Euthyroid is safe to take during pregnancy.
Is the use of Euthyroid 50 Tablet safe during breastfeeding?
Euthyroid may have very limited harmful effects for breastfeeding women.
What is the effect of Euthyroid 50 Tablet on the Kidneys?
Using Euthyroid does not have any harmful effects on kidneys.
What is the effect of Euthyroid 50 Tablet on the Liver?
Euthyroid is completely safe for the liver.
What is the effect of Euthyroid 50 Tablet on the Heart?
Euthyroid is completely safe for the heart.
Euthyroid 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Euthyroid 50 Tablet unless your doctor advises you to do so -
Is this Euthyroid 50 Tablet habit forming or addictive?
No, you will not get addicted to Euthyroid 50 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Euthyroid 50 Tablet since it will not make you feel sleepy.
Is it safe?
Euthyroid 50 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Euthyroid 50 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Euthyroid 50 Tablet
Taking Euthyroid 50 Tablet with food is safe.
Interaction between Alcohol and Euthyroid 50 Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Euthyroid 50 Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Levoxyl (levothyroxine sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 769-770